Evaluating the Effectiveness of New Biologics in Hidradenitis Suppurativa
Xeljanz (Tofacitinib): Tofacitinib is a Janus kinase (JAK) enzyme inhibitor developed for the treatment of rheumatoid arthritis. It has also been approved for psoriatic arthritis and ulcerative colitis. Tofacitinib works by inhibiting JAK enzymes, which